Indiana University

Research teams explored the performance of circulating cell-free DNA and stool DNA testing to find colorectal cancer in average-risk individuals.

The test detects blood gene expression biomarkers that are predictive of high hallucination and high delusion states and future hospitalizations. 

Using a machine learning model for distinguishing individuals with or without COPD, researchers identified dozens of new and known risk loci.